Idaho Admin. Code r. 24.36.01.011 - DEFINITIONS AND ABBREVIATIONS (O - Z)

The definitions set forth in Sections 54-1705 and 37-2701, Idaho Code, are applicable to these rules. In addition, the following terms have the meanings set forth below: (3-28-23)

01. Parenteral Admixture. The preparation and labeling of sterile products intended for administration by injection. (3-28-23)

02. Pharmaceutical Care Services. A broad range of services, activities and responsibilities intended to optimize drug-related therapeutic outcomes for patients consistent with Rule 100. Pharmaceutical care services may be performed independent of, or concurrently with, the dispensing or administration of a drug or device and also encompasses services provided by way of DTM under a collaborative practice agreement. Pharmaceutical care services are not limited to, but may include one (1) or more of the following: (3-28-23)

a. Performing or obtaining necessary assessments of the patient's health status, including the performance of health screening activities or testing; (3-28-23)

b. Reviewing, analyzing, evaluating, formulating or providing a drug utilization plan; (3-28-23)

c. Monitoring and evaluating the patient's response to drug therapy, including safety and effectiveness; (3-28-23)

d. Coordinating and integrating pharmaceutical care services within the broader health care management services being provided to the patient; (3-28-23)

e. Ordering and interpreting laboratory tests; (3-28-23)

f. Performing drug product selection, substitution, prescription adaptation, or refill authorization as provided in these rules; and (3-28-23)

g. Prescribing drugs and devices as provided in these rules. (3-28-23)

03. PDMP. Prescription Drug Monitoring Program. (3-28-23)

04. Prescriber. An individual currently licensed, registered, or otherwise authorized to prescribe and administer drugs in the course of professional practice. (3-28-23)

05. Purple Book. The list of licensed biological products with reference product exclusivity and biosimilarity or interchangeability evaluations published by the FDA under the Public Health Service Act. (3-28-23)

06. Readily Retrievable. Records are considered readily retrievable if they are able to be completely and legibly produced upon request within seventy-two (72) hours. (3-28-23)

07. Reconstitution. The process of adding a diluent to a powdered medication to prepare a solution or suspension, according to the product's labeling or the manufacturer's instructions. (3-28-23)

08. Restricted Drug Storage Area. The area of a drug outlet where prescription drugs are prepared, compounded, distributed, dispensed, or stored. (3-28-23)

09. Therapeutic Equivalent Drugs. Products assigned an "A" code by the FDA in the Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) and animal drug products published in the FDA Approved Animal Drug Products (Green Book). (3-28-23)

10. USP-NF. United State Pharmacopeia-National Formulary. (3-28-23)

Notes

Idaho Admin. Code r. 24.36.01.011